Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Feasibility of Using NeuraSignal Transcranial Doppler Robot

NCT: NCT06565442 · NOT_YET_RECRUITING

NCT IDNCT06565442
StatusNOT_YET_RECRUITING
Start Date2026-06-15
Completion2027-12-15

Brief Summary

The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves

Frequently Asked Questions

What is Feasibility of Using NeuraSignal Transcranial Doppler Robot?

Feasibility of Using NeuraSignal Transcranial Doppler Robot is a clinical trial registered under NCT06565442. Current status: NOT_YET_RECRUITING.

What is the status of NCT06565442?

The current status of NCT06565442 (Feasibility of Using NeuraSignal Transcranial Doppler Robot) is: NOT_YET_RECRUITING.

When did Feasibility of Using NeuraSignal Transcranial Doppler Robot start?

Feasibility of Using NeuraSignal Transcranial Doppler Robot started on 2026-06-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑